Biogen Inc.
BIIB Healthcare Drug Manufacturers General
Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024. In the quarter to June 2026, revenue grew 3.42%, EPS fell 84.8%, free cash flow grew 103.3% and total debt rose 16.0%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.
Follow BIIB
Biogen Inc. (BIIB) Book value per share
Biogen Inc.'s book value per share at the end of fiscal 2025 was 125×, up 8.55% from 115× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 128×. Over the past ten years it has ranged from 40.6× (fiscal 2015) to 125× (fiscal 2025) — the current reading is the highest in ten years. Biogen Inc. ranks 1st of 21 Drug Manufacturers General companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 125× | 8.55% |
| FY2024 | 115× | 12.25% |
| FY2023 | 102× | 11.00% |
| FY2022 | 92.1× | 25.36% |
| FY2021 | 73.5× | 10.68% |
| FY2020 | 66.4× | (6.84%) |
| FY2019 | 71.3× | 12.10% |
| FY2018 | 63.6× | 7.33% |
| FY2017 | 59.3× | 6.70% |
| FY2016 | 55.5× | 36.66% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 128× | 0.71% |
| Mar 2026 | 127× | 1.68% |
| Dec 2025 | 125× | 0.34% |
| Sep 2025 | 124× | 3.18% |
| 42 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| BIIB Biogen Inc. | 128× |
| SNY Sanofi compare | 33.8× |
| AZN AstraZeneca PLC compare | 32.5× |
| AMGN Amgen Inc. compare | 21.6× |
| PFE Pfizer Inc. compare | 15.0× |
| GSK GSK PLC Sponsored ADR compare | 11.5× |
| BMY Bristol Myers Squibb Company compare | 10.9× |
| GILD Gilead Sciences, Inc. compare | 9.4× |
| NVO Novo Nordisk A/S compare | 7.8× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on BIIB
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement